[1]孟庆军,孟 磊,金保哲,等.依达拉奉联合亚低温治疗重型颅脑损伤临床疗效分析[J].新乡医学院学报,2016,33(11):963-966.[doi:10.7683/xxyxyxb.2016.11.007]
 MENG Qing-jun,MENG Lei,JIN Bao-zhe,et al.Curative effect of edaravone combined with mild hypothermia in treatment of severe craniocerebral injury[J].Journal of Xinxiang Medical University,2016,33(11):963-966.[doi:10.7683/xxyxyxb.2016.11.007]
点击复制

依达拉奉联合亚低温治疗重型颅脑损伤临床疗效分析
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
33
期数:
2016年11
页码:
963-966
栏目:
临床研究
出版日期:
2016-11-05

文章信息/Info

Title:
Curative effect of edaravone combined with mild hypothermia in treatment of severe craniocerebral injury
作者:
孟庆军1孟 磊2金保哲2时会敏1周文科2
(1.郑州市第一人民医院神经外科,河南 郑州 450000;2.新乡医学院第一附属医院神经外科,河南 卫辉 453100)
Author(s):
MENG Qing-jun1MENG Lei2JIN Bao-zhe2SHI Hui-min1ZHOU Wen-ke2
(1.Department of Neurosurgery,the First People′s Hospital of Zhengzhou,Zhengzhou 450000,Henan Province,China;2.Department of Neurosurgery,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China)
关键词:
重型颅脑损伤依达拉奉亚低温治疗
Keywords:
severe craniocerebral injuryedaravonemild hypothermia
分类号:
R651.1+5
DOI:
10.7683/xxyxyxb.2016.11.007
文献标志码:
A
摘要:
目的 探讨依达拉奉注射液联合头颅局部亚低温治疗重型颅脑损伤的临床疗效。方法 将200例重型颅脑损伤患者随机分为对照组和观察组,每组100例。对照组患者给予常规药物和对症处理,观察组患者在对照组治疗基础上加用依达拉奉注射液联合头颅局部亚低温治疗,比较2组患者入院当天或急诊术后以及入院后4、7、14 d的格拉斯哥昏迷(GCS)评分和脑水肿变化情况;患者出院当天格拉斯哥预后功能(GOS)评分以及随访3个月时远期生活质量评估(KPS)得分。结果 对照组患者治疗过程中死亡13例(13%),观察组死亡6例(6%),观察组患者病死率显著低于对照组(P<0.05);2组患者入院当天或急诊术后GCS评分比较差异无统计学意义(P>0.05),入院后4、7、14 d GCS评分观察组患者显著高于对照组(P<0.05);2组患者入院当天或急诊术后以及入院后4、7、14 d相邻2次测定颅脑水肿面积的差值比较差异均有统计学意义(P<0.05),且观察组显著优于对照组(P<0.05);出院当天观察组和对照组患者GOS评分分别为4.45±0.57、3.99±0.64,观察组患者GOS评分显著高于对照组(P<0.05);出院后3个月,观察组和对照组患者KPS得分分别为93.24±5.89、81.41±6.72,观察组患者KPS得分显著高于对照组(P<0.05)。结论 依达拉奉注射液联合头颅局部亚低温治疗重型颅脑损伤有显著的脑保护作用。
Abstract:
Objective To explore the clinical curative effect of edaravone combined with mild hypothermia in treatment of acute severe craniocerebral injury.Methods Two hundred patients with severe craniocerebral injury were divided into control group and observation group by random digits table,with 100 patients in each group.The patients in control group were given conventional drugs and symptomatic treatment;based on these,the patients in observation group were treated with edaravone combined with mild hypothermia.The Glasgow coma scale(GCS) scores and brain edema change situation of patients at admission day or after emergency operation and 4,7,14 d after hospitalization were compared between the two groups;the Glasgow outcome scale(GOS) scores of patients at discharged the day from hospital and long-term karnofsky performance scale(KPS) scores of patients after following-up 3 months were recorded and compared between the two groups.Results Thirteen patients(13%)in the control group and 6 patients in the observation group(6%) died during the treatment;the mortality rate of patients in the observation group was significantly lower than that in the control group (P<0.05).There was no significant difference in GCS scores of patients on admission day or after emergency operation between the two groups(P>0.05);but the GCS scores of patients in the observation group at 4,7,14 d after hospitalization were significantly higher than those in the control group (P<0.05).The cerebral edema fluctuation area of patients in the observation group at admission day or after emergency operation and 4,7,14 d after hospitalization was significantly lower than that in the control group (P<0.05).The GOS score of patients at discharged the day in the observation group and control group was 4.45±0.57 and 3.99±0.64 respectively;there was statistic difference of GOS score between the two groups(P<0.05).The KPS score of patients after following-up for 3 months in observation group and control group was 93.24±5.89 and 81.41±6.72 respectively;the KPS score of patients in the observation group was significantly higher than that in the control group (P<0.05).Conclusion Edaravone injection combined with local mild hypothermia have a conspicuous neuroprotective effect in treatment of severe craniocerebral injury.

参考文献/References:

[1] 罗飚.老年重型颅脑损伤患者49例临床特点分析[J].中国老年学杂志,2012,32(5):1034-1035.
[2] 丛树国,孙红杰,赵鸿雁,等.早期机械通气配合亚低温对重型颅脑损伤疗效的影响[J].中国现代医生,2012,50(2):33-34.
[3] CROSSLEY S,REID J,MCLATCHIE R,et al.A systematicreview of therapeutic hypothermia for adult patients followingtraumatic brain injury[J].Crit Care,2014,18(2):R75.
[4] TU Y,CHEN C,SUN H T,et al.Combination of temperature sensitive stem cells and mild hypothermia:a new potential therapy for severe traumatic brain injury[J].J Neurotrauma,2012,29(14):2393-2403.
[5] 孙洪涛,涂悦,魏正军,等.亚低温状态下脑多参数监测对重型颅脑创伤患者应用常规降颅压手段的评价[J].中华神经外科杂志,2013,29(2):116-119.
[6] 刘西,李建明,林新国.依达拉奉治疗急性重型颅脑损伤的疗效观察[J].白求恩军医学院学报,2011,9(1):9-11.
[7] SETTIN A,ABDEL-HADY H,EL-BAZ R,et al.Gene polymorphisms of TNF-alpha(-308),IL-10(-1082),IL-6(-174),and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease[J].Pediatr Cardiol,2007,28(5):363-371.
[8] XIE Z Y,ZHUANG M H,LIN L,et al.Changes of plasma reactive protein in patients with craniocerebral injury before and after hyperbaric oxygen ationrolled study[J].Neural Regener Action Res,2007,2(5):314-317.
[9] 周良辅.现代神经外科学[M].上海:复旦大学出版社,2010:210-236.
[10] 杨先文,王凡,张跃,等.30例颅脑损伤所致颅神经损伤患者临床诊疗分析[J].西部医学,2013,25(10):1502-1504,1507.
[11] NAG S,KAPADIA A,STEWAN D J.Review:molecular pathogenesis of blood bminbarrier breakdown in acute brain injury[J].Neumpathol App Neumbiol,2011,37(1):3-23.
[12] 孟磊,周文科,金保哲,等.成年SD大鼠海马齿状回神经干细胞分离培养和鉴定的改良[J].中国实用神经疾病杂志,2014,8(1):1-4.
[13] ZHU Y,LIU C,SUN Z.Early combined therapy with pharmacologically induced hypothermia and edaravone exerts neuroprotective effects in a rat model of intracerebral hemorrhage[J].Cell Biochem Biophys,2015,73(2):581-587.
[14] ZHAO R,SHI W Z,ZHANG Y M,et al.Montelukast,a cysteinyl leukotriene receptor-1 antagonist,attenuates chronic brain injury after focal cerebral ischaemia in mice and rats[J].J Pharm Pharmacol,2011,63(4):550-557.
[15] SHAPIRO H,SINGER P.Beyond the classic eicosanoids:peripherally-acting oxygenated metabolites of polyunsaturated fatty acids mediate pain associated with tissue injury and inflammation[J].Prostaglandins Leukot Essent Fatty Acids,2016,111(1):45-61.
[16] 季莉莉,郝冬琳,马爱金,等.胞磷胆碱钠联合甘露醇和依达拉奉治疗大面积脑梗死疗效观察[J].新乡医学院学报,2014,31(12):1009-1010,1014.
[17] 卢少军.依达拉奉联合巴曲酶治疗急性期脑梗死疗效观察[J].新乡医学院学报,2011,28(6):743-745.
[18] JING G,YAO X,LI Y.Mild hypothermia for treatment of diffuse axonal injury:a quantitative analysis of diffusion tensor imaging[J].Neural Regen Res,2014,9(2):190-197.
[19] BUSTO R,GLOBUS M Y,DIETRICH W D,et al.Effect of mild hypothermia on ischemia induced release of neurotransmitters and free fatty acids in rat brain[J].Stroke,1989,20(7):904-910.
[20] 赵明亮,董化江,杨细平,等.颅脑创伤后海马区钾-氯协同转运蛋白-2、γ-氨基丁酸的表达变化及亚低温治疗对其影响[J].新乡医学院学报,2014,31(11):886-888.
[21] 徐大伟,周文科,黄立勇,等.亚低温联合胸腺喷丁对脑出血患者预后的影响[J].新乡医学院学报,2013,30(3):199-201.
[22] SUN H,ZHENG M,WANG Y,et al.Brain tissue partial pressure of oxygen predicts the outcome of severe traumatic brain injury under mild hypothermia treatment[J].Neuropsychiatr Dis Treat,2016,12(1):2125-2129.
[23] AHMED A I,BULLOCK M R.Hypothermia in traumatic brain injury[J].Neurosurg Clin N Am,2016,27(4):489-497.
[24] 王渊,唐安华,肖振鹏,等.早期机械通气联合亚低温治疗急性重型颅脑损伤疗效观察[J].山东医药,2011,51(20):64-65.

相似文献/References:

[1]李浩,靳怀明,李志华.老年人重型颅脑损伤后应激性溃疡72例分析[J].新乡医学院学报,2001,18(05):356.
[2]金保哲,张新中,周国胜.重型颅脑损伤开颅术中急性脑膨出63例临床分析[J].新乡医学院学报,2007,24(05):522.
[3]卢少军.依达拉奉联合巴曲酶治疗急性期脑梗死疗效观察[J].新乡医学院学报,2011,28(06):000.
[4]徐跃.重型颅脑损伤患者气管插管时机探讨[J].新乡医学院学报,2012,29(01):000.
[5]屈亚云,武莉芳,张秀敏,等.依达拉奉对肺癌胸腔镜手术中单肺通气相关肺损伤的保护作用[J].新乡医学院学报,2016,33(12):1054.[doi:10.7683/xxyxyxb.2016.12.010]
 QU Ya-yun,WU Li-fang,ZHANG Xiu-min,et al.Protective effect of edaravone on injury of lungs induced by one lung ventilation in lung cancer patients undergoing thorascopic surgery[J].Journal of Xinxiang Medical University,2016,33(11):1054.[doi:10.7683/xxyxyxb.2016.12.010]
[6]胡均贤,徐春林.早期肠内营养对重型颅脑损伤患者免疫功能及并发症的影响[J].新乡医学院学报,2016,33(12):1071.[doi:10.7683/xxyxyxb.2016.12.014]
 HU Jun-xian,XU Chun-lin.Effect of early enteral nutrition on immune function and complications in patients with severe craniocerebral injury[J].Journal of Xinxiang Medical University,2016,33(11):1071.[doi:10.7683/xxyxyxb.2016.12.014]
[7]邢俊领,张永森,吕林亚,等.血管内栓塞术后应用依达拉奉对颅内动脉瘤患者认知功能的影响[J].新乡医学院学报,2020,37(3):266.[doi:10.7683/xxyxyxb.2020.03.016]
 XING Junling,ZHANG Yongsen,LYU Linya,et al.Effect of edaravone on cognitive function of patients with intracranial aneurysm after endovascular embolization[J].Journal of Xinxiang Medical University,2020,37(11):266.[doi:10.7683/xxyxyxb.2020.03.016]
[8]钱时德,赵 全,焦冬生,等.依达拉奉联合重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死疗效观察[J].新乡医学院学报,2020,37(11):1040.[doi:10.7683/xxyxyxb.2020.11.008]
 QIAN Shide,ZHAO Quan,JIAO Dongsheng,et al.Effect of edaravone combined with recombinant tissue type plasminogen activator intravenous thrombolysis in the treatment of acute cerebral infarction[J].Journal of Xinxiang Medical University,2020,37(11):1040.[doi:10.7683/xxyxyxb.2020.11.008]
[9]陈 娟.尤瑞克林联合依达拉奉治疗急性脑梗死疗效观察[J].新乡医学院学报,2019,36(1):060.[doi:10.7683/xxyxyxb.2019.01.012]
 CHEN Juan.Effect of urinary kallidinogenase combined with edaravone in the treatment of acute cerebral infarction[J].Journal of Xinxiang Medical University,2019,36(11):060.[doi:10.7683/xxyxyxb.2019.01.012]

更新日期/Last Update: 2016-11-05